Answers are grounded in this paper and cite their sources.
Nocebo effects occur when an adverse effect on the patient arises from the patient's own negative expectations. In accordance with informed consent, providers often disclose information that results in unintended adverse outcomes for the patient. While this may adhere to the principle of autonomy, it violates the doctrine of “primum non nocere,” given that side-effect disclosure may cause those side effects. In this article we build off previous work, particularly by Wells and Kaptchuk (2012 Wells, R. E., and T. J. Kaptchuk. 2012. To tell the truth, the whole truth, may do patients harm: The problem of the nocebo effect for informed consent. American Journal of Bioethics 12:22–29.[Taylor & Francis Online], [Web of Science ®] , [Google Scholar]) and by Cohen (2013 Cohen, S. 2013. Nudging and informed consent. American Journal of Bioethics 13 (6):3–11.[Taylor & Francis Online], [Web of Science ®] , [Google Scholar]), to suggest ethical guidelines that permit nondisclosure in the case when a nocebo effect is likely to occur on of the basis of nonmaleficence. We accept that that autonomy vis-à-vis informed consent must be forestalled, but salvage much of its role by elaborating a practical clinical approach to postencounter follow-up. In doing so, we reconcile a clinically practicable process of determining conditions of disclosure with long-standing ethical commitments to patients.
No takes yet. Share an insight, caveat, or question.
Fortunato et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: